Cabrita et al. describe a gene expression signature associated with the presence of TLS in melanoma tumors to correlate with response to PD-1 blockade when applied to on-treatment tumor biopsies of two independent melanoma patient cohorts. Here, PDCD1 is linked to melanoma.